These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7685934

  • 1. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
    Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC, Gores G, Hay E, Dickson ER, Krom RA.
    Transplantation; 1993 Jun; 55(6):1332-9. PubMed ID: 7685934
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA.
    Transplantation; 1996 Dec 15; 62(11):1588-92. PubMed ID: 8970613
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA.
    Am J Hypertens; 1995 Jun 15; 8(6):598-605. PubMed ID: 7544983
    [Abstract] [Full Text] [Related]

  • 6. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.
    Clin Transplant; 1995 Jun 15; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [Abstract] [Full Text] [Related]

  • 7. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation.
    Textor SC, Wilson DJ, Lerman A, Romero JC, Burnett JC, Wiesner R, Dickson ER, Krom RA.
    Transplantation; 1992 Jul 15; 54(1):74-80. PubMed ID: 1631948
    [Abstract] [Full Text] [Related]

  • 8. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM.
    Transplantation; 1995 Feb 27; 59(4):530-6. PubMed ID: 7533345
    [Abstract] [Full Text] [Related]

  • 9. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M, Meehan SM, Josephson MA, Wit EJ, Woodle ES, Thistlethwaite JR.
    Am J Kidney Dis; 1999 Jul 27; 34(1):69-84. PubMed ID: 10401019
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
    Hohage H, Brückner D, Arlt M, Buchholz B, Zidek W, Spieker C.
    Clin Nephrol; 1996 May 27; 45(5):342-4. PubMed ID: 8738668
    [Abstract] [Full Text] [Related]

  • 12. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK, Xie XB, Peng FH, Wang Y, Jiang Y, Lan GB, Fang CH, Nie MH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb 27; 32(1):59-62. PubMed ID: 17344588
    [Abstract] [Full Text] [Related]

  • 13. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M.
    Transplantation; 1995 Jan 15; 59(1):31-40. PubMed ID: 7530868
    [Abstract] [Full Text] [Related]

  • 14. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
    McDiarmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW.
    J Pediatr Gastroenterol Nutr; 1995 Apr 15; 20(3):291-9. PubMed ID: 7541834
    [Abstract] [Full Text] [Related]

  • 15. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P.
    Transplantation; 1994 Jul 27; 58(2):170-8. PubMed ID: 7518975
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX, Shan HT, Fu SJ, Du CF, Ma JJ, Xu J, Deng WF, Wang YB.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov 27; 23(11):1146-8. PubMed ID: 14625173
    [Abstract] [Full Text] [Related]

  • 17. Distal tubular acidosis induced by FK506.
    Heering P, Ivens K, Aker S, Grabensee B.
    Clin Transplant; 1998 Oct 27; 12(5):465-71. PubMed ID: 9787958
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 20. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ, Hilbrands LB, van Hamersvelt HW, Koene RA, Huysmans FT.
    Nephrol Dial Transplant; 1998 Feb 27; 13(2):423-6. PubMed ID: 9509456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.